Elrashdy M Redwan: is a Ph.D. Professor, he obtained his Ph.D. in biomedicine and immunology from Cairo University of Egypt (1995) and was promoted to a permanent senior researcher position at the Department of Biomedical Research, VACSERA, where he conducted research on viral and bacterial vaccine development and vaccine immunology. In 1998, he was nominated for a permanent professorship at the City for Scientific Research and Technology Applications (New Borg Alrab, Alexandria 21934, Egypt), where he established his Laboratory of the Protective and Therapeutic Proteins within the Protein Research Department. For two years, Prof. Redwan worked as visiting scientist at the Scripps Research Institute (TSRI, San Diego) on monoclonal antibody humanization and crystallization. Over the past 20 years, Prof. Redwan has focused his scientific research on the topics related to life-treating infectious diseases, such as enteric pathogens, Haemophilus influenzae type B virus (HIb), hepatitis C virus (HCV), and hepatitis B virus (HBV). He also looks for roles of natural products as potential anti-viral and anti-bacterial alternative medicine. Prof. Redwan has established a cluster of platforms for the production of new biopharmaceuticals and/or biosimilars. Over the years, he supervised and trained many Ph.D. and Master's Degree students, as well as Postdoctoral Fellows in the fields of immunology and infectious diseases. Prof. Redwan published many scientific articles and book chapters, served as an editor and reviewer for many academic journals, and worked as a Guest Professor in several national and foreign universities and institutes. He served as an expert in national organizations, such as the Egyptian Academy of Scientific Research and Technologies. Prof. Redwan received many national academic honors (2008, 2009, 2010). Currently, he is a Sabbaticals Professor at the Biological Science Department, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia. ORCID:0000-0001-8246-0075, Researcher ID: I-1769-2012, Scopus Author ID: 8519808500 https://www.mdpi.com/journal/vaccines/special_issues/Immunological_Studies